- Home
- MNPR vs CODI Comparison
MNPR vs CODI Comparison
Compare MNPR & CODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- CODI
- Stock Information
- Founded
- MNPR 2014
- CODI 2005
- Country
- MNPR United States
- CODI United States
- Employees
- MNPR N/A
- CODI N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- CODI Home Furnishings
- Sector
- MNPR Health Care
- CODI Consumer Discretionary
- Exchange
- MNPR Nasdaq
- CODI Nasdaq
- Market Cap
- MNPR 531.6M
- CODI 480.0M
- IPO Year
- MNPR 2019
- CODI 2006
- Fundamental
- Price
- MNPR $92.78
- CODI $5.96
- Analyst Decision
- MNPR Strong Buy
- CODI Buy
- Analyst Count
- MNPR 13
- CODI 2
- Target Price
- MNPR $97.83
- CODI $26.00
- AVG Volume (30 Days)
- MNPR 161.9K
- CODI 1.4M
- Earning Date
- MNPR 11-13-2025
- CODI 10-29-2025
- Dividend Yield
- MNPR N/A
- CODI 16.56%
- EPS Growth
- MNPR N/A
- CODI N/A
- EPS
- MNPR N/A
- CODI N/A
- Revenue
- MNPR N/A
- CODI $2,198,233,000.00
- Revenue This Year
- MNPR N/A
- CODI $15.09
- Revenue Next Year
- MNPR N/A
- CODI $8.26
- P/E Ratio
- MNPR N/A
- CODI N/A
- Revenue Growth
- MNPR N/A
- CODI 11.87
- 52 Week Low
- MNPR $18.67
- CODI $5.30
- 52 Week High
- MNPR $105.00
- CODI $24.32
- Technical
- Relative Strength Index (RSI)
- MNPR 64.12
- CODI 46.13
- Support Level
- MNPR $74.58
- CODI $5.33
- Resistance Level
- MNPR $84.06
- CODI $6.13
- Average True Range (ATR)
- MNPR 6.71
- CODI 0.41
- MACD
- MNPR 0.32
- CODI 0.00
- Stochastic Oscillator
- MNPR 95.22
- CODI 57.59
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest
Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.